---
title: Cytel vs Parexel
slug_a: cytel
slug_b: parexel
site: cro
review_signal_gate: closed
canonical_path: /compare/cytel/parexel
---

# Cytel vs Parexel

Side-by-side profile data from each company listing on this directory.

## Cytel

- Profile: [/companies/cytel](/companies/cytel)

Cytel — Cytel provides data science and advanced analytics solutions across the drug development lifecycle, from discovery through commercialization, including clinical trial design, adaptive trial strategies, real-world evidence, and regulatory support.

Services: 12. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Computational & In-Silico Drug Discovery
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- Translational Research

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Discovery
- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Functional Service Provider (FSP)

## Parexel

- Profile: [/companies/parexel](/companies/parexel)

Parexel — Parexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation.

Services: 17. Modalities: 3. Indications: 12. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (17).

### Services

- Biomarker Assays
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- Translational Research
- Genomics & Sequencing Services

### Modalities

- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Neurology
- Psychiatry
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Ophthalmology
- Gastroenterology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Functional Service Provider (FSP)